TipRanks on MSN

HeartBeam (NASDAQ: BEAT) secures FDA 510(k) clearance for 12-lead ECG synthesis software following successful appeal

Austin, Texas, United States, December 10th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...
Rutland Herald

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

Unlike any single-lead or 6-lead consumer device, HeartBeam’s patented cable-free technology captures the heart’s electrical signals in three non-coplanar dimensions and synthesizes them into a ...

HeartBeam stock soars after FDA clearance for 12-lead ECG synthesis software

Investing.com -- HeartBeam Inc (NASDAQ:BEAT) stock surged 52.6% in premarket trading Wednesday after the medical technology company announced it received FDA 510 (k) clearance for its 12-lead ...
Cantech Letter

Heartbeam stock is a buy, this analyst says

Santa Clara–based HeartBeam is developing a cable-free, credit-card-sized ECG recorder that captures 3D cardiac signals and synthesizes them into a diagnostic-quality 12-lead ECG. The platform’s ...
Business Wire

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it ...
Open Heart

Association of blood pressure control with atrial and ventricular ectopy in SPRINT

Background Previous epidemiological studies demonstrated that premature atrial contractions (PACs) and premature ventricular ...
Medical Design & Outsourcing

Electrocardiography ADC architectures, trade-offs and use cases

Veterinary ECGs face added challenges, as muscle tremors, shivering and motion artifacts can easily dominate the signal.

HeartBeam (BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, ...

Investornewsbreaks Heartbeam Inc. (NASDAQ: BEAT) Secures FDA 510(K) Clearance For 12-Lead ECG Synthesis Software Following Successful Appeal

Secures FDA 510(K) Clearance For 12-Lead ECG Synthesis Software Following Successful Appeal. HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through ...